Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF
© Jääskeläinen et al; licensee BioMed Central Ltd. 2008
Received: 19 October 2007
Accepted: 11 January 2008
Published: 11 January 2008
The competitiveness of two Tula hantavirus (TULV) isolates, TULV/Lodz and TULV/Moravia, was evaluated in interferon (IFN) -competent and IFN-deficient cells. The two isolates differ in the length of the open reading frame (ORF) encoding the nonstructural protein NSs, which has previously been shown to inhibit IFN response in infected cells.
In IFN-deficient Vero E6 cells both TULV isolates survived equally well. In contrast, in IFN-competent MRC5 cells TULV/Lodz isolate, that possesses the NSs ORF for the full-length protein of 90 aa, survived for more consequent passages than TULV/Moravia isolate, which contains the ORF for truncated NSs protein (66–67 aa).
Our data show that expression of a full-length NSs protein is beneficial for the virus survival and competitiveness in IFN-competent cells and not essential in IFN-deficient cells. These results suggest that the N-terminal aa residues are important for the full activity of the NSs protein.
Hantaviruses (genus Hantavirus, family Bunyaviridae) are carried by rodents and insectivores and present all over the world . Some hantaviruses are nonpathogenic, and others are human pathogens. Pathogenic hantaviruses from Asia and Europe cause hemorrhagic fever with renal syndrome (HFRS) while hantaviruses in the Americas cause hantavirus pulmonary syndrome (HPS). The genome of hantaviruses consists of three segments of a negative-sense single-stranded RNA. The large (L) segment codes for RNA polymerase (L protein), the medium (M) segment for two glycoproteins Gn and Gc, and the small (S) segment for the nucleocapsid (N) protein . Hantaviruses carried by Cricetidae rodents (subfamilies Arvicolinae, Neotominae, and Sigmodontinae) have in their S segment an additional +1 open reading frame (ORF) for the nonstructural protein NSs . Hantaviruses carried by Muridae rodents (subfamily Murinae) do not possess the NSs ORF . Most recently, we have shown that the hantaviral NSs protein is an inhibitor (albeit not a strong one) of the interferon (IFN) response .
The IFN response is one of the main host defence mechanisms against viruses. Virus infection induces expression of several IFN genes, in most cell types first the genes encoding IFN-β and IFN-α4 . These IFN proteins are then secreted from an infected cell and they bind to corresponding receptors on the same or neighbouring cells starting a signaling cascade that leads to expression of hundreds of IFN-stimulated genes producing powerful antiviral proteins such as myxovirus resistance gene (Mx), 2'–5' oligoadenylate synthetases (OAS) and protein kinase stimulated by dsRNA (PKR) (reviewed in ). Many viruses have developed special mechanisms to evade the host immune response (for a review, see [6, 7]). For example, orthobunyaviruses and phleboviruses from the Bunyaviridae family encode NSs proteins that inhibit the host cell immunity by suppressing host transcription [8–11]. Our previous data show that the NSs ORF in Tula (TULV) and Puumala (PUUV) hantaviruses is functional . TULV NSs protein was seen with coupled in vitro transcription and translation from S segment cDNA. PUUV NSs protein was seen with Western blot in infected Vero E6 cells. Transiently expressed NSs proteins of both TULV and PUUV inhibited the activities of IFN-β promoter, and nuclear factor kappa B (NF-κB)- and interferon regulatory factor-3 (IRF-3) responsive promoters in COS-7 cells. The decline in the expression of IFN-β mRNA was evident in TULV- infected or TULV- NSs expressing IFN-competent MRC5 cells. These data strongly suggested that the hantaviral NSs protein is an IFN antagonist.
Selection of primers for isolate-specific amplification of the S and M segment sequences of two TULV isolates
Primers used in TULV isolate-specific RT-PCR assays.
Primer name (isolate, segment, forw/rev)
Amplicon size (bp)
LVSF783 (Lodz, S, forw)
LVSR1026 (Lodz, S, rev)
LodzG2F426 (Lodz, M, for)
LodzG2R953 (Lodz, M, rev)
LodzG2F554 (Lodz, M, nested PCR, forw)
LodzG2R814 (Lodz, M, nested PCR, rev)
TulSF895 (Moravia, S, forw)
MVSR1149 (Moravia, S, rev)
MorG2F83 (Moravia, M, forw)
MorG2R817 (Moravia, M, rev)
MorG2F444 (Moravia, M, nested PCR, forw)
MorG2R579 (Moravia, M, nested PCR, rev)
Survival and competitiveness of TULV isolates in IFN-deficient cells
Summary of RT-PCR detection of TULV S and M segment RNA.
Infection with TULV isolates
Lodz & Moravia
Lodz & Moravia
1st passage from VeroE6
Survival and competitiveness of TULV isolates in IFN-competent cells
MRC5 cells were infected with the mixture of TULV/Lodz and TULV/Moravia isolates. The supernatant was collected and used to infect fresh cells. Altogether 6 passages were performed and the RNA was analyzed by RT-PCR assays. While both S and M segments of TULV/Lodz were detected during three passages, the corresponding segments of TULV/Moravia were detected only at passage 1 (Fig. 2). When MRC5 cells were infected with the first passage supernatant from Vero E6 cells infected with the mixture of two viruses, the outcome was essentially the same (Fig. 3). Neither of the isolates survived all six passages, and the TULV/Lodz isolate probably producing 90 aa-long NSs protein survived better than TULV/Moravia isolate capable of producing a shorter version of the NSs protein. Interestingly, under these experimental settings both TULV isolates survived better.
NSs ORF is found in many but not in all hantaviruses . Both nonpathogenic hantaviruses (e.g. TULV and Prospect Hill virus) and pathogenic ones (e.g. Sin Nombre virus (SNV) and Andes virus) have NSs ORF, and presumably produce the NSs protein. Thus this protein is probably not the sole determinant of hantavirus pathogenicity. An NSs ORF is present also in the S segments of bunyaviruses of the genera Orthobunyavirus, Tospovirus, and Phlebovirus . The NSs proteins of orthobunya- and phleboviruses counteract the IFN response by inhibiting RNA polymerase II and hence downregulate the general transcription in infected cells [8–11]. By analogy one would assume a similar anti-IFN function for hantaviral NSs protein. According to our data, host protein synthesis is not severely affected by infection with TULV and PUUV. The NSs proteins of these viruses decrease the IFN response by inhibiting the activation of IFN-β promoter via NF-κB and IRF-3 pathways . Thus the suppression of IFN-β induction by TULV, PUUV, and also Prospect Hill virus, New York virus, SNV, and Andes virus reported by several research groups [17–21] could be, at least in part, attributed to the inhibitory activity of the NSs protein. In hantaviruses lacking the NSs ORF, the IFN response could be antagonized by other means, e.g. by glycoproteins [21, 23].
Here we have studied the competitiveness of two TULV isolates, TULV/Lodz and TULV/Moravia, after double infection in IFN-deficient and IFN-competent cells. These two TULV isolates differ in the length of their NSs ORF, which provided an opportunity to gain insights on function(s) of the NSs protein in vivo. TULV/Lodz isolate was expected to be more resistant to the IFN response than TULV/Moravia. This appeared to be the case indeed, supporting our earlier conclusion that the NSs protein is involved in the counteraction of IFN response, and suggesting that the N-terminal aa residues in the molecule are needed for the full activity of the NSs protein of TULV. It would be interesting to examine the anti-IFN activity of the NSs proteins of other hantaviruses, especially of SNV and SNV-like viruses that possess shorter NSs ORFs than PUUV and TULV .
Interestingly, even the more resistant of two TULV isolates, TULV/Lodz, failed to survive in MRC5 cells for more than five consequent passages. This temporary survival is in sharp contrast to the persistent, life-long infection, which TULV causes in its natural rodent host [24, 25]. One possible explanation is that, in the course of natural infection, the virus infects only a few IFN-competent cells and thus can avoid an immediate clearance by the host innate immunity. In Vero E6 cells the full-length NSs protein of TULV/Lodz did not appear beneficial for the competitiveness of this isolate suggesting that the full-length NSs protein is not essential for the virus in IFN-deficient cells.
So far no hantavirus with the entire NSs ORF deleted has been found in nature or engineered using reverse genetics. However, an interesting clone of PUUV strain Sotkamo was recently obtained by focus purification technique from the original Vero E6 cell culture isolate . This clone, Sotkamo-delNSs, carries a stop codon instead of Trp-21 codon in the NSs ORF, and thus could produce a truncated NSs protein (transcription presumably starts from Met-24), which is of the same size as in TULV/Moravia isolate. Most notably, Sotkamo-delNSs clone grows to substantially lower titers (about 10 times) than parental virus in IFN-competent A549 cells while in IFN-deficient Vero cells both viruses replicated with the same efficacy (Andreas Rang, personal communication). This is in agreement with our results on TULV and supports the idea that the production of the full-length NSs protein is beneficial for the viral growth in IFN-competent cells but not vital in IFN-deficient cells.
Reassortant variants could have been formed in the course of double infection with two TULV isolates. One could also assume that the reassortants possessing the S segment of TULV/Lodz isolate would have higher chances to survive in MRC5 cells (provided that the full-length NSs protein is a potent pro-survival factor). Unfortunately, our current isolate-specific RT-PCR assays are not quantitative and thus this hypothesis could not be properly evaluated. We are currently trying to develop real-time PCR assays to clarify this issue.
The data presented here show that TULV/Lodz survives better in IFN-competent MRC5 cells than TULV/Moravia. This is probably due to the function of NSs protein, which in the former isolate is full-length while in the latter truncated and hence less active. The results are in agreement with our earlier findings on the anti-IFN function of TULV NSs protein . The production of the full-length or truncated NSs protein appeared to have no effect on the competitiveness of TULV isolates in Vero E6 cells suggesting that in IFN-deficient cells the full-length NSs protein is not essential for virus growth.
Cells and viruses
Vero E6 cells were cultured in modified Eagle's medium (MEM) and MRC5 cells in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS), 2 mM L-glutamine, penicillin and streptomycin in 5% CO2 at 37°C. TULV strain Lodz  and the cell culture-adapted isolate of TULV strain Moravia Tula/Moravia/Ma5302V/94  were used.
Titration of viruses
Confluent Vero E6 cells grown on 6-well plate wells were infected with several virus dilutions (0.5 ml) for 1 h. About 5 ml of 42°C 0.5% agarose, 8% FCS, 20 mM HEPES, 1 mM -glutamine, penicillin and streptomycin in MEM was added onto the cells. The plate was incubated for 10 min at room temperature (RT). After 11 days of incubation at 37°C the cells were fixed with 10% formaldehyde for 30 min at RT. Agarose was removed and cells were washed three times 5 min with 0.15% Tween-20 in PBS. The antibody reaction was done at RT for 1 h with 1% human anti-PUUV serum in 5% FCS, 0.15% Tween-20 in PBS. After washes, conjugate incubation was done at RT for 1 h with peroxidase-conjugated rabbit anti-human IgG diluted 1:150 in 0.15% Tween-20 in PBS. After washing, cells were stained with Liquid DAB+ Substrate Chromogen System (DakoCytomation, Glostrup, Denmark) according to the manufacturer's instructions. The titer was calculated by dividing the number of foci from a well having 2–5 foci, by the amount of virus put onto the cells.
About 80% confluent MRC5 cells grown on 25 cm2 flasks were infected with TULV/Lodz and TULV/Moravia for 1 h (both MOI 0.2). The virus inoculum was then replaced with 10 ml DMEM. After 7 days of infection the supernatant (approximately 10 ml) was collected and the part of it (2 ml) was used to infect new cells. The remaining infected cells were used for RNA isolation. Consequently, the passage 2 supernatant was used to infect fresh cells 7 days post infection. Altogether 6 passages and samples for RNA isolation were collected. Confluent Vero E6 cells grown on 25 cm2 flasks with medium containing 5% serum were infected with TULV/Lodz and TULV/Moravia (both 800 FFU). Lodz-Moravia passage 1 supernatant and samples for RNA isolation were collected 14 days post infection. New Vero E6 cells were infected with 1 ml of passage 1 supernatant with 9 ml medium containing 2% serum. After 14 days passage 2 samples were collected and fresh cells were infected with it. Totally 10 passages and samples for RNA isolation were assembled. The first passage of TULV/Lodz and TULV/Moravia mixed infection supernatant collected from Vero E6 cells was also used to infect MRC5 cells like above (MOI 0.04).
Cells from a 25-cm2 flask were suspended to 3 ml of TriPure Isolation Reagent (Roche, Basel, Switzerland). RNA was isolated essentially according to the manufacturer's recommendation. Before use, the RNA was re-precipitated twice with ethanol and 3 M Na-acetate pH 5.3. RNA was dissolved in 25 μl H2O.
Reverse transcription was performed with 5 μl RNA and strain-specific primers using the SuperScript™ First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. PCR was done with AmpliTaq® DNA Polymerase (Applied Biosystems, Foster City, CA) with 5 μl cDNA, which was amplified with 250 μM dNTPs, 4 mM MgCl2, 1 μM of primers, and 0.03 U/μl polymerase. The isolate-specific primers are listed in Table 1. For Vero E6 samples Moravia S-segment PCR was done with the following primers : forward MVSF780 5'-CCTGAAGAAAAGTGGTCCTAGT-3' and reverse MVSR1149 (Table 1). Later it was noticed that primer TulSF895 worked better together with MVSR1149 and this pair of primers was used in the amplification of MRC5-cell samples (Table 1). Due to the low sensitivity of the amplification of the M-segment sequences, the nested PCR was needed. PCR-amplicons were analyzed in 1.7% agarose gels.
Olli Vapalahti is thanked for providing the virus titration protocol and Satu Kurkela for help in virus titrations. Rick Randall and Dan Young are thanked for the MRC5 cells. Elisabeth Gustafsson, Leena Kostamovaara and Tytti Manni are thanked for excellent technical assistance. The study was sponsored by the University of Helsinki (the Young Scientist's grant for KMJ), The Academy of Finland (grant 212313) and Sigrid Jusélius Foundation, Helsinki.
- Nichol ST, Beaty BJ, Elliott RM, Goldbach R, Plyusnin A, Schmaljohn CS, Tesh RB: Bunyaviridae. In Virus Taxonomy. VIIIth Report of the International Committee on Taxonomy of Viruses. Edited by: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. Amsterdam: Elsevier Academic Press; 2005:695-716.
- Plyusnin A: Genetics of hantaviruses: implications to taxonomy. Arch Virol 2002, 147: 665-682. 10.1007/s007050200017View ArticlePubMed
- Jääskeläinen KM, Kaukinen P, Minskaya ES, Plyusnina A, Vapalahti O, Elliott RM, Weber F, Vaheri A, Plyusnin A: Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol 2007, 79: 1526-1537. 10.1002/jmv.20948View Article
- Marié I, Durbin JE, Levy DE: Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998, 17: 6660-6669. 10.1093/emboj/17.22.6660PubMed CentralView ArticlePubMed
- García-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: a lesson in detente. Science 2006, 312: 879-882. 10.1126/science.1125676View ArticlePubMed
- García-Sastre A: Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses. Curr Top Microbiol Immunol 2004, 283: 249-280.PubMed
- Haller O, Kochs G, Weber F: The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006, 344: 119-130. 10.1016/j.virol.2005.09.024View ArticlePubMed
- Le May N, Dubaele S, De Santis LP, Billecocq A, Bouloy M, Egly JM: TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004, 116: 541-550. 10.1016/S0092-8674(04)00132-1View ArticlePubMed
- Thomas D, Blakqori G, Wagner V, Banholzer M, Kessler N, Elliott RM, Haller O, Weber F: Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 2004, 279: 31471-31477. 10.1074/jbc.M400938200View ArticlePubMed
- Blakqori G, Weber F: Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol 2005, 79: 10420-10428. 10.1128/JVI.79.16.10420-10428.2005PubMed CentralView ArticlePubMed
- Léonard VH, Kohl A, Hart TJ, Elliott RM: Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response. J Virol 2006, 80: 9667-9675. 10.1128/JVI.00822-06PubMed CentralView ArticlePubMed
- Song JW, Baek LJ, Song KJ, Skrok A, Markowski J, Bratosiewicz-Wasik J, Kordek R, Liberski PP, Yanagihara R: Characterization of Tula virus from common voles ( Microtus arvalis ) in Poland: evidence for geographic-specific phylogenetic clustering. Virus Genes 2004, 29: 239-247. 10.1023/B:VIRU.0000036384.50102.cfView ArticlePubMed
- Vapalahti O, Lundkvist Å, Kukkonen SK, Cheng Y, Gilljam M, Kanerva M, Manni T, Pejcoch M, Niemimaa J, Kaikusalo A, Henttonen H, Vaheri A, Plyusnin A: Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus , family Bunyaviridae . J Gen Virol 1996, 77: 3063-3067.View ArticlePubMed
- Young DF, Andrejeva L, Livingstone A, Goodbourn S, Lamb RA, Collins PL, Elliott RM, Randall RE: Virus replication in engineered human cells that do not respond to interferons. J Virol 2003, 77: 2174-2181. 10.1128/JVI.77.3.2174-2181.2003PubMed CentralView ArticlePubMed
- Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, Chilcote RR, Rowley JD: Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 1988, 85: 5259-5263. 10.1073/pnas.85.14.5259PubMed CentralView ArticlePubMed
- Pensiero MN, Sharefkin JB, Dieffenbach CW, Hay J: Hantaan virus infection of human endothelial cells. J Virol 1992, 66: 5929-5936.PubMed CentralPubMed
- Temonen M, Lankinen H, Vapalahti O, Ronni T, Julkunen I, Vaheri A: Effect of interferon-alpha and cell differentiation on Puumala virus infection in human monocyte/macrophages. Virology 1995, 206: 8-15. 10.1016/S0042-6822(95)80014-XView ArticlePubMed
- Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER: Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 2002, 99: 13837-13842. 10.1073/pnas.192298899PubMed CentralView ArticlePubMed
- Kraus AA, Raftery MJ, Giese T, Ulrich R, Zawatzky R, Hippenstiel S, Suttorp N, Krüger DH, Schönrich G: Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses. J Virol 2004, 78: 6143-6150. 10.1128/JVI.78.12.6143-6150.2004PubMed CentralView ArticlePubMed
- Prescott J, Ye C, Sen G, Hjelle B: Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol 2005, 79: 15007-15015. 10.1128/JVI.79.24.15007-15015.2005PubMed CentralView ArticlePubMed
- Spiropoulou CF, Albariño CG, Ksiazek TG, Rollin PE: Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 2007, 81: 2769-2776. 10.1128/JVI.02402-06PubMed CentralView ArticlePubMed
- Nam JH, Hwang KA, Yu CH, Kang TH, Shin JY, Choi WY, Kim IB, Joo YR, Cho HW, Park KY: Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells. Virus Genes 2003, 26: 31-38. 10.1023/A:1022373904357View ArticlePubMed
- Alff PJ, Gavrilovskaya IN, Gorbunova E, Endriss K, Chong Y, Geimonen E, Sen N, Reich NC, Mackow ER: The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 2006, 80: 9676-9686. 10.1128/JVI.00508-06PubMed CentralView ArticlePubMed
- Plyusnin A, Vapalahti O, Lankinen H, Lehväslaiho H, Apekina N, Myasnikov Y, Kallio-Kokko H, Henttonen H, Lundkvist Å, Brummer-Korvenkontio M, Gavrilovskaya I, Vaheri A: Tula virus: a newly detected hantavirus carried by European common voles. J Virol 1994, 68: 7833-7839.PubMed CentralPubMed
- Plyusnin A, Cheng Y, Vapalahti O, Pejcoch M, Unar J, Jelinkova Z, Lehväslaiho H, Lundkvist Å, Vaheri A: Genetic variation in Tula hantaviruses: sequence analysis of the S and M segments of strains from Central Europe. Virus Res 1995, 39: 237-250. 10.1016/0168-1702(95)00086-0View ArticlePubMed
- Rang A, Heider H, Ulrich R, Krüger DH: A novel method for cloning of non-cytolytic viruses. J Virol Methods 2006, 135: 26-31. 10.1016/j.jviromet.2006.01.014View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.